Clinical trial
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in…
NCT00357682 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00357682 |
|---|---|
| Title | A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia |
| Official title | A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia |
| Acronym | AspECT |
| Lead sponsor | University of Oxford, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Precancerous Condition |
| Intervention type | Drug |
| Interventions | Esomeprazole, Aspirin |
| Enrollment | 2,557 |
| Start date | Mar 10, 2005 |
| Primary completion | May 31, 2017 |
| Completion | May 31, 2017 |
| First posted | Jul 27, 2006 |
| Last update posted | May 1, 2025 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: